Francois Bachand

Sherbrooke, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Biosensor-guided discovery of peptide inhibitors targeting the ribosomal protein uS5-PDCD2 chaperone interaction.

Biosensor-guided discovery of peptide inhibitors targeting the ribosomal protein uS5-PDCD2 chaperone interaction.

Journal: The Journal of biological chemistry

Published: October 22, 2025

Biosensor-Guided Discovery of Peptide Inhibitors Targeting the Ribosomal Protein uS5-PDCD2 Chaperone Interaction.

Biosensor-Guided Discovery of Peptide Inhibitors Targeting the Ribosomal Protein uS5-PDCD2 Chaperone Interaction.

Journal: The Journal of biological chemistry

Published: October 22, 2025

A homozygous synonymous NOP58 variant causes a neurodevelopmental disorder by impairing maturation of pre-ribosomal RNAs.

A homozygous synonymous NOP58 variant causes a neurodevelopmental disorder by impairing maturation of pre-ribosomal RNAs.

Journal: HGG advances

Published: June 24, 2025

A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapy.

A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapy.

Journal: Brachytherapy

Published: June 16, 2025

RNase III cleavage sites spread across splice junctions enforce sequential snoRNA processing.

RNase III cleavage sites spread across splice junctions enforce sequential snoRNA processing.

Journal: EMBO reports

Published: May 30, 2025

Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).

Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).

Journal: International journal of radiation oncology, biology, physics

Published: April 18, 2025

Biallelic variants in the conserved ribosomal protein chaperone gene PDCD2 are associated with hydrops fetalis and early pregnancy loss.

Biallelic variants in the conserved ribosomal protein chaperone gene PDCD2 are associated with hydrops fetalis and early pregnancy loss.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 10, 2025

SnoBIRD: a tool to identify C/D box snoRNAs and refine their annotation across all eukaryotes.

SnoBIRD: a tool to identify C/D box snoRNAs and refine their annotation across all eukaryotes.

Journal: Nucleic acids research

Published: April 04, 2025

Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment.

Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 10, 2025

A Randomized Comparison of High-Dose-Rate and Low-Dose-Rate Prostate Brachytherapy Combined With External Beam Radiation Therapy for Unfavorable Prostate Cancer: Efficacy Results After Median Follow-up of 74 Months.

A Randomized Comparison of High-Dose-Rate and Low-Dose-Rate Prostate Brachytherapy Combined With External Beam Radiation Therapy for Unfavorable Prostate Cancer: Efficacy Results After Median Follow-up of 74 Months.

Journal: International journal of radiation oncology, biology, physics

Published: January 17, 2025

HDR brachytherapy combined with external beam radiotherapy for unfavorable localized prostate cancer: A single center experience from inception to standard of care.

HDR brachytherapy combined with external beam radiotherapy for unfavorable localized prostate cancer: A single center experience from inception to standard of care.

Journal: Brachytherapy

Published: September 16, 2024

Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance.

Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance.

Journal: Nucleic acids research

Published: August 19, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026